SPECT IMAGING WITH I-123 ISOPROPYL AMPHETAMINE IN ASYMPTOMATIC HIV SEROPOSITIVE PERSONS
LaFrance N, Pearlson G, Schaerf F, McArthur J, Bascom M, Kumar A, Turek J, Cole P, Chen J, Wagner H. SPECT IMAGING WITH I-123 ISOPROPYL AMPHETAMINE IN ASYMPTOMATIC HIV SEROPOSITIVE PERSONS. Clinical Nuclear Medicine 1988, 13: 393. DOI: 10.1097/00003072-198805000-00042.Peer-Reviewed Original ResearchHIV encephalopathyAsymptomatic HIV-seropositive personsMini-Mental State EvaluationHIV-seropositive personsForamen of MonroSeropositive personsSeropositive individualsBasal gangliaFirst manifestationEarly predictorNormal controlsPatientsSubcortical regionsPET studiesIsopropyl amphetamineSPECT imagingCortical asymmetryAsymmetry indexSPECT slicesTrails BSingle studyDementiaAIDSSPECT dataMonthsBRAIN IMAGING WITH IODOAMPHETAMINE (IMP) IN PATIENTS WITH HUNTINGTON'S DISEASE (HD)
LaFrance N, Pearlson G, Folstein S, Cole P, Turek J, Kumar A, Bascom M, McDonald A, Folstein M, Wagner H. BRAIN IMAGING WITH IODOAMPHETAMINE (IMP) IN PATIENTS WITH HUNTINGTON'S DISEASE (HD). Clinical Nuclear Medicine 1988, 13: 392. DOI: 10.1097/00003072-198805000-00039.Peer-Reviewed Original ResearchEarly HD patientsMini-Mental StateHD patientsHuntington's diseaseNeurological examinationMini-Mental State scoresDuration of diseaseGenotype-positive individualsEarly Huntington's diseaseMental state scoresForamen of MonroPotential therapeutic interventionsNormal CTFirst manifestationPositive individualsMRI studiesPatientsPreclinical measuresTherapeutic interventionsIodoamphetamineIMP accumulationDiseaseBrain imagingState scoresSignificant decrement